Carolina Care Excellence Award Winners Announced
Please join us in congratulating neurologists Nina Browner, MD, and Richard Murrow, MD!
Please join us in congratulating neurologists Nina Browner, MD, and Richard Murrow, MD!
Retired pediatric nurse Betty F. Allen, RN, passed away on Thursday, December 17 from non-COVID-19 related issues. Betty grew up in Pittsboro, NC and graduated from Watt’s School of Nursing in Durham, NC in 1974. Betty served as a nurse for 46 years with a special interest in the neuroscience field. She retired from UNC … Read more
Alyssa Draffin, LCSW, recently went to extraordinary lengths to ensure that a 12-year-old boy with undiagnosed autism receive an evaluation that would qualify him for therapy and special services.
Serena Spudich, MD, professor of neurology and chief of Neurological Infections & Global Neurology at Yale University, is the first recipient of this award named in honor of beloved UNC neurology professor Kevin Robertson, PhD.
Assistant Professor of Neurology and Neurosurgery Casey Olm-Shipman, MD, MS, was selected as an AMA Health Systems Scholar, a one-year mentored program aimed at developing Health Systems Science (HSS) leaders. In support of her recent appointment as UNC’s Director of HSS for Graduate Medical Education, Dr. Olm-Shipman’s AMA project will be the development and implementation … Read more
UNC BRIC researchers led by Weili Lin, PhD, used magnetic resonance imaging techniques to show the emergence of a functional flexible brain during early infancy.
The UNC Department of Neurology is proud to announce that child neurologists Senyene Hunter, MD, PhD, and Diana Cejas, MD, MPH, are this year’s recipients of the UNC Broyhill Research Award in Child Neurology.
The Center for Animal MRI (CAMRI) at the Biomedical Research Imaging Center (BRIC), led by Ian Shih, PhD, received two National Institutes of Health grants totaling $2.6 million for a new MRI instrument and to upgrade an existing MRI system.
UNC Neurology’s Research Center of Excellence for Lewy Body Dementia participated as a study site for a phase 2 clinical trial that met its primary objective of improving cognition in LBD patients who received neflamapimod.